Prognostic Significance of Biomarkers and Instrumental Parameters in St-Segment Elevation Myocardial Infarction for Justifying an Individualized Treatment Strategy
Keywords:
Remain high, cases complicate, cardiovascular diseasesAbstract
Acute myocardial infarction (AMI) remains one of the leading causes of mortality and disability worldwide. According to the World Health Organization, cardiovascular diseases claim the lives of more than 17 million people annually, with a significant proportion of these deaths being associated with acute coronary syndrome and, in particular, ST-segment elevation myocardial infarction (STEMI). Despite the rapid development of interventional treatment methods, mortality rates during the acute phase of myocardial infarction remain high, especially in cases complicated by adverse events.
References
Januzzi J.L. et al. Natriuretic Peptide Testing for Heart Failure. Circulation. 2005;112(10):1426–1430.
Kociol R.D. et al. Importance of BNP Measurement in ST-Elevation Myocardial Infarction. Journal of the American College of Cardiology (JACC). 2010;55(11):1182–1189.
Killip T., Kimball J.T. Treatment of Myocardial Infarction in a Coronary Care Unit. American Journal of Cardiology. 1967;20(4):457–464.
Yellon D.M., Hausenloy D.J. Myocardial Reperfusion Injury. New England Journal of Medicine. 2007;357:1121–1135.
Kiselev A.E. et al. Antioxidant Properties of Quercetin and Its Derivatives. Cardiology. 2018;58(3):59–63.
Safronova E.A. Use of Corvitin in Acute Myocardial Infarction. Modern Therapy. 2020;2:34–38.
Ministry of Health of the Republic of Uzbekistan. Analysis of Statistics on Cardiovascular Diseases for 2022. Tashkent, Uzbekistan; 2022
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Abdujabbarova D.E., Mukhamedova B.F., Ashurova M.U., Abduvaliyeva Sh.O., Urolov Sh.S., Allayorov S.A.
This work is licensed under a Creative Commons Attribution 4.0 International License.
